HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vlems, F A Articles by van Muijen, G N P Search for Related Content PubMed PubMed Citation Articles by Vlems, F A Articles by van Muijen, G N P

Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue

¹ Department of Surgery, University Medical Centre Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands
² Department of Pathology, University Medical Centre Nijmegen
³ Department of Medical Oncology, University Medical Centre Nijmegen

Correspondence to:
Dr F Vlems, Department of Pathology, University Medical Centre St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands;
f.vlems{at}pathol.azn.nl

Aims: Despite informative staging of patients with colorectal cancer, some patients with localised disease at diagnosis will develop recurrence or metastasis. Attempts to improve staging include sensitive detection of disseminated tumour cells in blood and bone marrow by reverse transcriptase polymerase chain reaction (RT-PCR). The results of this study have been considered in relation to the controversial results in the literature to elucidate the usefulness of cytokeratin 20 (CK20) RT-PCR to detect disseminated tumour cells further.

Patients/Methods: Blood and bone marrow samples from 30 patients with colorectal cancer were studied by CK20 RT-PCR. Specificity was evaluated in 47 blood and 15 bone marrow samples from non-cancer controls. In addition, the expression of CK20 mRNA and protein was studied in normal and tumour colon tissue samples.

Results: CK20 expression was detected in nine of 30 and nine of 19 of the blood and bone marrow samples from patients with colorectal cancer, respectively. In non-cancer control blood and bone marrow samples, CK20 expression was detected in 10 of 47 and four of 15, respectively. A difference between patient and control samples may be observed in terms of frequency of positive PCR tests. In tissue samples, CK20 mRNA expression was downregulated in tumour compared with normal colon tissue.

Conclusions: CK20 expression was downregulated in tumour tissue compared with normal colon and a background expression of CK20 was seen in some control blood and bone marrow samples. Despite a lack of standardisation (which hampers comparison of studies), these results, together with other reports in the literature, suggest that CK20 may still be a suitable marker, but that background expression and threshold setting should be studied further.

Keywords: cytokeratin 20; colorectal cancer; disseminated tumour cells; reverse transcriptase polymerase chain reaction

Abbreviations: CK, cytokeratin; MNC, mononuclear cells; PBGD, porphobilinogen deaminase; PBS, phosphate buffered saline; RT-PCR, reverse transcriptase polymerase chain reaction

This article has been cited by other articles:

				J. Sastre, M. L. Maestro, J. Puente, S. Veganzones, R. Alfonso, S. Rafael, J. A. Garcia-Saenz, M. Vidaurreta, M. Martin, M. Arroyo, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables Ann. Onc., May 1, 2008; 19(5): 935 - 938. [Abstract] [Full Text] [PDF]

				S. Hundt, U. Haug, and H. Brenner Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1935 - 1953. [Abstract] [Full Text] [PDF]

				S. Sadahiro, T. Suzuki, Y. Maeda, S. Yurimoto, S. Yasuda, H. Makuuchi, A. Kamijo, and C. Murayama Detection of Carcinoembryonic Antigen Messenger RNA-Expressing Cells in Peripheral Blood 7 Days After Curative Surgery is a Novel Prognostic Factor in Colorectal Cancer Ann. Surg. Oncol., March 1, 2007; 14(3): 1092 - 1098. [Abstract] [Full Text] [PDF]

				G. Giribaldi, S. Procida, D. Ulliers, F. Mannu, R. Volpatto, G. Mandili, L. Fanchini, O. Bertetto, G. Fronda, L. Simula, et al. Specific Detection of Cytokeratin 20-Positive Cells in Blood of Colorectal and Breast Cancer Patients by a High Sensitivity Real-Time Reverse Transcriptase-Polymerase Chain Reaction Method J. Mol. Diagn., February 1, 2006; 8(1): 105 - 112. [Abstract] [Full Text] [PDF]

				S. Sadahiro, T. Suzuki, K. Ishikawa, T. Saguchi, Y. Maeda, S. Yasuda, H. Makuuchi, S. Yurimoto, and C. Murayama Detection of Carcinoembryonic Antigen Messenger RNA-Expressing Cells in Portal and Peripheral Blood During Surgery Does Not Influence Relapse in Colorectal Cancer Ann. Surg. Oncol., December 1, 2005; 12(12): 988 - 994. [Abstract] [Full Text] [PDF]

				N. Dandachi, M. Balic, S. Stanzer, M. Halm, M. Resel, T. A. Hinterleitner, H. Samonigg, and T. Bauernhofer Critical Evaluation of Real-Time Reverse Transcriptase-Polymerase Chain Reaction for the Quantitative Detection of Cytokeratin 20 mRNA in Colorectal Cancer Patients J. Mol. Diagn., November 1, 2005; 7(5): 631 - 637. [Abstract] [Full Text] [PDF]

				G Cserni Nodal staging of colorectal carcinomas and sentinel nodes J. Clin. Pathol., May 1, 2003; 56(5): 327 - 335. [Abstract] [Full Text] [PDF]